Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs mycophenolate sodium with tacrolimus and basiliximab in French transplant recipients
2012-000137-39Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of everolimus in solid organ transplant rejection (SOTR) (2 arms), sponsored by Novartis. Started Aug 2012; status: completed.
02
Drugs
everolimus
03
Conditions
solid organ transplant rejection (SOTR)
Beyond the preview
Go deeper on 2012-000137-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000137-39.